Inhibition of VCAM-1 expression on mouse vascular smooth muscle cells by lobastin via downregulation of p38, ERK 1/2 and NF-κB signaling pathways
- 521 Downloads
Atherosclerosis is a chronic inflammatory disease, the progression of which is associated with the increased expression of cell adhesion molecules on vascular smooth muscle cells (VSMCs). Lobastin is a new pseudodepsidone isolated from Stereocaulon alpinum, Antarctic lichen, which is known to have antioxidant and antibacterial activities. However, the nature of the biological effects of lobastin still remains unclear. In the present study, we examine the effect of lobastin on the expression of vascular cell adhesion molecules (VCAM-1) induced by TNF-α in the cultured mouse VSMC cell line, MOVAS-1. Pretreatment of VSMCs for 2 h with lobastin (0.1–10 μg/ml) concentration-dependently inhibited TNF-α-induced protein expression of VCAM-1. Lobastin also inhibited TNF-α-induced production of intracellular reactive oxygen species (ROS). Lobastin abrogated TNF-α-induced phosphorylation of p38 and ERK 1/2, but not JNK, and also inhibited TNF-α-induced NK-κB activation. In addition, lobastin suppressed TNF-α-induced IκB kinase activation, subsequent degradation of IκBα and nuclear translocation of p65 NF-κB. Our results indicate that lobastin downregulates the TNF-α-mediated induction of VCAM-1 in VSMC by inhibiting the p38, ERK 1/2 and NF-κB signaling pathways and intracellular ROS generation. Thus, lobastin may be an important regulator of inflammation in the atherosclerotic lesion and a novel therapeutic drug for the treatment of atherosclerosis.
KeywordsLobastin Vascular cell adhesion molecule-1 Atherosclerosis NF-κB MAPK
This research was supported by the grant of the Ministry of Oceans and Fisheries’ R&D project (PM13030) and the Korea Polar Research Institute (KOPRI) project (PE13040).
Compliance with ethical standards
Conflict of interest
The authors have no conflicts of interest to declare.
- Kim J-Y, Park H-J, Um SH, Sohn E-H, Kim B-O, Moon E-Y, Rhee D-K, Pyo S (2012) Sulforaphane suppresses vascular adhesion molecule-1 expression in TNF-α-stimulated mouse vascular smooth muscle cells: involvement of the MAPK, NF-κB and AP-1 signaling pathways. Vascul Pharmacol 56:131–141PubMedCrossRefGoogle Scholar
- Lee CW, Lin WN, Lin CC, Luo SF, Wang JS, Pouyssegur J, Yang CM (2006) Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in human tracheal smooth muscle cells: involvement of MAPKs, NF-kappaB, p300, and histone acetylation. J Cell Physiol 207:174–186PubMedCrossRefGoogle Scholar
- Luo SF, Fang RY, Hsieh HL, Chi PL, Lin CC, Hsiao LD, Wu CC, Wang JS, Yang CM (2010) Involvement of MAPKs and NF-κB in tumor necrosis factor α-induced vascular cell adhesion molecule 1 expression in human rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 62:105–116PubMedCrossRefGoogle Scholar
- Øvstedal DO, Smith RL (2001) Lichens of Antarctica and South Georgia: a guide to their identification and ecology. Cambridge University Press, CambridgeGoogle Scholar
- Park B, Yim J-H, Lee H-K, Kim B-O, Pyo S (2014) Ramalin inhibits VCAM-1 expression and adhesion of monocyte to vascular smooth muscle cells through MAPK and PADI4-dependent NF-kB and AP-1 pathways. Biosci Biotechnol Biochem 79:1–14Google Scholar
- Saxena U, Medford R (2000) Vascular adhesion molecule-1 (VCAM-1), an inflammatory gene target for new therapeutics. Curr Opin Cardiovasc Pulm Renal Invest Drugs 2:258–262Google Scholar
- Vazquez G, Smedlund K, Tano J-YK, Lee R (2012) Molecular and cellular aspects of atherosclerosis: emerging roles of TRPC channels. Coron Artery Dis 51:91–102Google Scholar